According to WuXi Biologics's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 3.47674. At the end of 2022 the company had a P/S ratio of 14.7.
Year | P/S ratio | Change |
---|---|---|
2022 | 14.7 | -52.79% |
2021 | 31.0 | -50.26% |
2020 | 62.4 | 117.09% |
2019 | 28.8 | 34.99% |
2018 | 21.3 | -18.48% |
2017 | 26.1 |